Home » Topics » Conferences

Conferences
RSS

Multiple mechanisms of action proposed for beneficial cardiac effects of HNS-32

March 31, 2000

Meperidine analogues under study as dopamine uptake inhibitors by NIDA and collaborators

March 31, 2000

DuPont identifies potent, orally active CRF antagonist

March 31, 2000

A-228839: synthesis of a new agent for blocking Ras function

March 31, 2000

Potentially safer antimigraine agents presented at ACS meeting by Canadian company

March 31, 2000

Hemodynamic effects of AH-1058 evaluated by telemetry in dogs

March 30, 2000

KT3-671 beneficial in diabetic nephropathy according to recent preclinical results

March 30, 2000

HMR-1556 selected for further evaluation as antiarrhythmic agent, presented to ACS

March 30, 2000

Inhibitors of cdk2 pursued by CV Therapeutics for use in restenosis

March 30, 2000

Benzimidazole inhibitors of V-ATPase designed at Fujisawa for osteoporosis Rx

March 30, 2000

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...